In conclusion, the abnormal expression of adenosine A1 receptor in the hippocampus of epileptic rats might be involved in the pathogenesis of epilepsy, NBTI mimics adenosine reducing epileptiform discharge through adenosine A1 receptor might provide a novel therapeutic approach toward the control of epilepsy. The gene discussed is ADORA1; the disease is epilepsy.